CLOs on the Move

Revance

www.revance.com

 
Revance Therapeutics is a biotechnology company developing neuromodulators for use in treating aesthetic and underserved therapeutic conditions, including muscle movement disorders and pain. The company`s lead drug candidate, DaxibotulinumtoxinA for Injection (RT002), is currently in development for the treatment of glabellar lines, cervical dystonia and plantar fasciitis with the potential to be the first long-acting neuromodulator. Revance has developed a proprietary, stabilizing excipient peptide technology designed to create novel, differentiated therapies. The company has a comprehensive pipeline based upon its peptide technology, including injectable and topical formulations of daxibotulinumtoxinA.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.revance.com
  • 7555 Gateway Boulevard
    Newark, CA USA 94560
  • Phone: 510.742.3400

Executives

Name Title Contact Details
Amie Krause
Chief Human Resources Officer, U.S. Profile
Caryn McDowell
Senior Vice President, General Counsel, and Corporate Secretary Profile
Caryn McDowell
Senior Vice President, General Counsel, and Corporate Secretary Profile

Similar Companies

R I Analytical Laboratories Inc

R I Analytical Laboratories Inc is a Warwick, RI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

AB Scientific

Welcome to AB Scientific. Suppliers of innovative products to Pharmaceutical, Clinical and Life Science laboratories in the UK and Ireland.

Cell Therapeutics

Cell Therapeutics, Inc is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Biolex Therapeutics

Biolex Therapeutics is a Pittsboro, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Globe Labs

Globe Labs Inc. is a Vancouver, BC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.